Kite: New data offers transparency into CAR T cell therapy manufacturing in real world setting

Retrieved on: 2021-04-07 15:08:54

Tags for this article:

Click the tags to see associated articles and topics

Kite: New data offers transparency into CAR T cell therapy manufacturing in real world setting. View article details on hiswai:

Excerpt

... relapsed/refractory diffuse large B cell lymphoma (DLBCL) and primary mediastinal large B cell lymphoma (PMBCL), said the biopharma company.

Article found on: www.biopharma-reporter.com